ipilimumab,nivolumab,5-FU,Leucovorin,Oxaliplatin,Docetaxel
bms
[]
 all pmmr. high risk pts after surgery, 96% n+, 15% r1. &gt;80% completed postop flot!! study shows need for flot as adjuvant.
Professor Med Onc + GI, researcher @MayoClinic. Interests: #colorectalcancer, #GIcancer, #Immunotherapy. #hereditarycancers. Views my own.@FASinicropeMD